liuweiwuling

has hepatoprotective activity; consists of Schisandra chinensis, fructus ligustri lucidi, forsythia, endives, rhizoma zedoariae, and ganoderma lucidum

Networked: 8 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Niu, Ming: 4 articles (01/2021 - 01/2018)
2.	Bai, Zhaofang: 3 articles (01/2021 - 01/2018)
3.	Xiao, Xiaohe: 3 articles (01/2021 - 01/2018)
4.	Bai, Zhao-Fang: 2 articles (01/2021 - 01/2018)
5.	Wang, Jia-Bo: 2 articles (01/2021 - 01/2018)
6.	Xiao, Xiao-He: 2 articles (01/2021 - 01/2018)
7.	Li, Ruishen: 2 articles (07/2018 - 01/2018)
8.	Liu, Huimin: 2 articles (07/2018 - 01/2018)
9.	Wang, Jiabo: 2 articles (07/2018 - 01/2018)
10.	Zhang, Congen: 2 articles (07/2018 - 01/2018)

Related Diseases

1.	Fibrosis (Cirrhosis) 09/11/2020 - "Effect of Liuweiwuling tablet on biochemical and virological parameters, and quality of life in patients with hepatitis B virus-related cirrhosis: A protocol for a systematic review and meta-analysis." 01/10/2018 - "Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways." 09/11/2020 - "Liuweiwuling (LWWL) tablet, a kind of plant-derived traditional Chinese medicine preparation, has been widely applied as a promising adjunctive drug for hepatitis B virus-related cirrhosis (HBVC). " 07/09/2018 - "Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats."
2.	Liver Cirrhosis (Hepatic Cirrhosis) 01/01/2014 - "When used in combination with entecavir, the TCM Liuweiwuling tablet is a safe therapy for CHB and its related liver fibrosis and may help to improve the QoL of these patients." 01/01/2014 - "A total of 430 patients with CHB-related liver fibrosis were randomly assigned to treatment groups for receipt of a 12-month course of the antiviral drug entecavir alone (control group) or in combination with the TCM Liuweiwuling tablets. "
3.	Liver Diseases (Liver Disease) 01/01/2018 - "First, we developed a comprehensive systems approach to enrich drug compound-liver disease networks to analyse the major predicted diseases of Liuweiwuling and discover its potential effect on liver failure. " 01/01/2021 - "The use of Liuweiwuling (LWWL), a traditional Chinese medicine formula, approved by the Chinese Food and Drug Administration for decreasing aminotransferase levels induced by different liver diseases. "
4.	Acute Liver Failure (Fulminant Hepatic Failure) 01/01/2018 - "Next, a classical pharmacology experiment was designed to validate the effects of Liuweiwuling on different models of fulminant liver failure induced by D-galactosamine/lipopolysaccharide (GalN/LPS) or thioacetamide (TAA). "
5.	Liver Failure 01/01/2018 - "First, we developed a comprehensive systems approach to enrich drug compound-liver disease networks to analyse the major predicted diseases of Liuweiwuling and discover its potential effect on liver failure. " 01/01/2018 - "A systems pharmacology-oriented discovery of a new therapeutic use of the TCM formula Liuweiwuling for liver failure."

Related Drugs and Biologics

1.	Tablets
2.	Carbon Tetrachloride (Tetrachloromethane)
3.	entecavir
4.	Therapeutic Uses
5.	Thioacetamide (Thioacetamid)
6.	Lipopolysaccharides
7.	Galactosamine
8.	Nonprescription Drugs (Patent Medicines)
9.	Antiviral Agents (Antivirals)
10.	Transaminases (Aminotransferases)

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)